Related references
Note: Only part of the references are listed.Angiotensin II Shifts Insulin Signaling Into Vascular Remodeling From Glucose Metabolism in Vascular Smooth Muscle Cells
Hirofumi Hitomi et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor
Gang Liu et al.
EXPERIMENTAL CELL RESEARCH (2011)
Aldosterone Enhances IGF-I-Mediated Signaling and Biological Function in Vascular Smooth Muscle Cells
Teresa Cascella et al.
ENDOCRINOLOGY (2010)
Insulin-Like Growth Factor-1 Receptor Expression Masks the Antiinflammatory and Glucose Uptake Capacity of Insulin in Vascular Smooth Muscle Cells
Niels Engberding et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Role of aldosterone and angiotensin II in insulin resistance: an update
Guido Lastra-Lastra et al.
CLINICAL ENDOCRINOLOGY (2009)
Vascular insulin resistance: A potential link between cardiovascular and metabolic diseases
Ivonne Hernandez Schulman et al.
CURRENT HYPERTENSION REPORTS (2009)
Aldosterone Inhibits Insulin-Induced Glucose Uptake by Degradation of Insulin Receptor Substrate (IRS) 1 and IRS2 via a Reactive Oxygen Species-Mediated Pathway in 3T3-L1 Adipocytes
Tsutomu Wada et al.
ENDOCRINOLOGY (2009)
Vascular Insulin-Like Growth Factor-I Resistance and Diet-Induced Obesity
Helen Imrie et al.
ENDOCRINOLOGY (2009)
Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats
Yukiko Nagai et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats
Jun Du et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-γ, and proinflammatory adipokines
Christine Guo et al.
CIRCULATION (2008)
Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS
J. H. O'Keefe et al.
DIABETES OBESITY & METABOLISM (2008)
Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells
Suwarni Diah et al.
EXPERIMENTAL CELL RESEARCH (2008)
The role of IGF-system in vascular insulin resistance
H. J. Arnqvist
HORMONE AND METABOLIC RESEARCH (2008)
Possible Involvement of Rho-Kinase in Aldosterone-Induced Vascular Smooth Muscle Cell Remodeling
Kayoko Miyata et al.
HYPERTENSION RESEARCH (2008)
Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells
Hirofumi Hitomi et al.
HYPERTENSION (2007)
Molecular genetics of experimental hypertension and the metabolic syndrome - From gene pathways to new therapies
Michal Pravenec et al.
HYPERTENSION (2007)
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study
Gilberta Giacchetti et al.
JOURNAL OF HYPERTENSION (2007)
Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells
Git S. Johansson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells
Hirofumi Hitomi et al.
JOURNAL OF HYPERTENSION (2006)
Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation
K Ishizawa et al.
HYPERTENSION (2005)
Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells
SI Chisalita et al.
DIABETOLOGIA (2005)
Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II
Y Taniyama et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability
A Nishiyama et al.
HYPERTENSION (2005)
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats
Y Nagai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes
JI Davies et al.
DIABETOLOGIA (2004)
Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension
A Nishiyama et al.
HYPERTENSION (2003)
Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension
A Nishiyama et al.
HYPERTENSION (2003)
Share Paper
